Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Aren’t Crazy About MVC Capital, Inc. (MVC) Anymore

Page 1 of 2

It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment opportunity. As a result, most investors pick their illusory “winners” by making a superficial analysis and research that leads to poor performance on aggregate. The Standard and Poor’s 500 Index returned 5.2% over the 12-month period ending October 30, while more than 51% of the constituents of the index underperformed the benchmark. Hence, a random stock picking process will most likely lead to disappointment. At the same time, the 30 most favored S&P 500 stocks by the hedge funds monitored by Insider Monkey (as of September 2014) generated a return of 9.5% over the same time span, with 63% of these stocks outperforming the benchmark. Of course, hedge funds do make wrong bets on some occasions and these get disproportionately publicized in the financial media, but piggybacking their moves can beat the broader market on average. That’s why we are going to go over recent hedge fund activity in MVC Capital, Inc. (NYSE:MVC).

MVC Capital, Inc. (NYSE:MVC) investors should pay attention to a decrease in activity from the world’s largest hedge funds in recent months. MVC was in an 8 hedge funds’ portfolios at the end of the third quarter of 2015. There were 10 hedge funds in our database with MVC holdings at the end of the previous quarter. The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity, but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as Merchants Bancshares,Inc. (NASDAQ:MBVT), Blueknight Energy Partners L.P. (NASDAQ:BKEP), and Five9 Inc (NASDAQ:FIVN) to gather more data points.

Follow Mvc Capital Inc. (NYSE:MVC)
Trade (NYSE:MVC) Now!

In today’s marketplace there are numerous signals investors can use to evaluate stocks. A duo of the most underrated signals are hedge fund and insider trading moves. Our experts have shown that, historically, those who follow the top picks of the best fund managers can beat the market by a superb margin (see the details here).

With all of this in mind, we’re going to check out the fresh action surrounding MVC Capital, Inc. (NYSE:MVC).

What have hedge funds been doing with MVC Capital, Inc. (NYSE:MVC)?

At the end of the third quarter, a total of 8 of the hedge funds tracked by Insider Monkey were bullish on this stock, a change of -20% from the previous quarter. With the smart money’s sentiment swirling, there exists a select group of notable hedge fund managers who were upping their holdings considerably (or already accumulated large positions).

Of the funds tracked by Insider Monkey, Chuck Royce’s Royce & Associates has the number one position in MVC Capital, Inc. (NYSE:MVC), worth close to $10.1 million, comprising 0.1% of its total 13F portfolio. Sitting at the No. 2 spot is Dov Gertzulin of DG Capital Management, with a $6.9 million position; the fund has an 8% of its 13F portfolio invested in the stock. Some other hedge funds and institutional investors that are bullish consist of Nelson Obus’s Wynnefield Capital, D. E. Shaw and Paul J. Isaac’s Arbiter Partners Capital Management.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!